Earnings To Be Announced Prior to Market Open on Tuesday
August 29th, 2023
TORONTO, Aug. 23,
2023 /CNW/ - Think Research Corporation
(TSXV: THNK) ("Think" or the "Company"), a company focused on
transforming healthcare through digital health software solutions,
announced today that it will release Second Quarter and
Year-to-Date Results prior to market open on Tuesday, August
29th, 2023. Think's financial statements and Management Discussion
and Analysis will be available under the Company's profile on SEDAR
and on the Company's website as of 7:15 a.m. Eastern Time.
Prior to market open on Tuesday August
29th, at 9:00 a.m.,
CEO Sachin Aggarwal and CFO John Hayes with
host a conference call to discuss the results, with a Q&A
session to follow.
TIME: 9:00AM EST, Tuesday August 29th, 2023
Conference Call Participant Details: To join the
conference call without operator assistance, you may register and
enter your phone number HERE to receive an instant
automated call back. Participants can also dial direct to be
entered to the call by an Operator:
Toronto: 416-764-8659
North American Toll Free: 1-888-664-6392
Webinar
URL: https://app.webinar.net/6WVYnEMnalm
Conference Replay
Local: 416-764-8677
North American Toll Free: 1-888-390-0541
Replay Entry Code: 197171 #
Expiration Date: 09/03/2023
About Think Research
Corporation
Think Research Corporation is an industry leader in delivering
knowledge-based digital health software solutions. The Company's
focused mission is to organize the world's health knowledge so
everyone gets the best care. Its evidence-based healthcare
technology solutions support the clinical decision-making process
and standardize care, to facilitate better health care outcomes.
The Company gathers, develops, and delivers knowledge-based
solutions globally to customers which typically includes enterprise
clients, hospitals, health regions, healthcare professionals, and /
or governments. The Company has gathered a significant amount of
data by building its repository of knowledge through its network
and group of companies, including acquired companies.
Think licenses its solutions to over 1600 facilities for over
326,000 primary care, acute care, and long-term care doctors,
nurses and pharmacists that rely on the content and data provided
by Think to support their practices. Over 3 million patients
and residents annually receive better care due to the essential
data that Think produces, manages and delivers.
In addition, the Company collects and manages pharmaceutical and
clinical trial data via the BioPharma Services entity that Think
acquired on September 10, 2021.
BioPharma Services is a leading provider of bioequivalence and
Phase 1 clinical research services to pharmaceutical companies
globally. Think's other services include a network of digital-first
primary care clinics and medical clinics that provide elective
surgery. Visit: www.thinkresearch.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this news release.
For more
information: https://www.thinkresearch.com/ca/investors/
SOURCE Think Research Corporation
